News Headlines Article

Johnson & Johnson puts up strong profit and revenue in Q4
Modern Healthcare

A big jump in prescription drug sales, particularly overseas, helped Johnson & Johnson swing to a large fourth-quarter profit after posting a huge loss a year earlier, when it took a $13.6 billion charge related to the late-2017 U.S. tax overhaul.The world’s biggest maker of healthcare products also benefited from an effective tax rate of 2.6% for the latest quarter, amounting to just $80 million. That was the main reason J&J topped Wall Street profit expectations, Credit Suisse analyst Vamil Divan wrote to investors.The company also reported lower spending on research and development, restructuring and interest charges.